{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T04:34:41Z","timestamp":1725597281534},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bpobgyn.2010.02.017","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T09:15:46Z","timestamp":1272705346000},"page":"593-604","source":"Crossref","is-referenced-by-count":12,"title":["Contraceptive options for women in selected circumstances"],"prefix":"10.1016","volume":"24","author":[{"given":"Edith","family":"Weisberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2010.02.017_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1054-139X(99)00095-6","article-title":"The determinants of sexual intercourse before age 16","volume":"27","author":"Paul","year":"2000","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib2","series-title":"Consent toolkit","author":"Brit Med Assoc (BMA)","year":"2003"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib3","first-page":"168","article-title":"Adolescent contraceptive care for the practicing paediatrician","volume":"20","author":"Duffy","year":"2009","journal-title":"Adolesc Med State Art Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib4","series-title":"Medical eligibility criteria for contraceptive use","author":"Department of Reproductive health","year":"2009"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib5","unstructured":"Faculty of Sexual and Reproductive Healthcare UK Medical eligibility criteria for contraceptive use RCOG 2009."},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2307\/2673787","article-title":"The NIH condom report: the glass is 90% full","volume":"33","author":"Cates","year":"2001","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2307\/2135721","article-title":"Condom slippage and breakage rates","volume":"24","author":"Trussell","year":"1992","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2307\/2991502","article-title":"Multiple sexual partners among U.S. adolescents and young adults","volume":"30","author":"Santelli","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003550.pub2","article-title":"Nonlatex versus latex male condoms for contraception","volume":"1","author":"Gallo","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0031-3955(05)70146-2","article-title":"The use of nonhormonal methods of contraception in adolescents","volume":"46","author":"Rieder","year":"1999","journal-title":"Pediatr Clin North Am."},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib11","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub2","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"3","author":"Arowojolu","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpag.2004.11.016","article-title":"Adolescents\u2019 experience with the combined estrogen and progestin transdermal contraceptive method. Ortho Evra","volume":"18","author":"Harel","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jadohealth.2009.02.007","article-title":"Attitudes toward the vaginal ring and transdermal patch among adolescents and young women","volume":"45","author":"Raine","year":"2009","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.07.013","article-title":"The contraceptive vaginal ring: female adolescents\u2019 knowledge, attitudes and plans for use","volume":"76","author":"Carey","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jadohealth.2007.12.007","article-title":"Adolescent experiences with the vaginal ring","volume":"43","author":"Epstein","year":"2008","journal-title":"Adolesc Health"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib19","unstructured":"Clinical Effectivness Unit FSRH. Pregestogen-only pill 2009 Clinical guidelines. June 2009."},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005214.pub2","article-title":"Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception","volume":"3","author":"Draper","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jc.75.4.1060","article-title":"Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects","volume":"75","author":"Theintz","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogeterone acetate contraception","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0021932000014760","article-title":"Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis","volume":"16","author":"Pardthaisong","year":"1984","journal-title":"J Biosoc Sci"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate","volume":"63","author":"Canto De Cetina","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archpedi.153.10.1068","article-title":"Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users","volume":"153","author":"Lim","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib28","first-page":"428","article-title":"Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate","volume":"41","author":"Cullins","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004568.pub3","article-title":"Combination injectable contraceptives for contraception","volume":"4","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpag.2008.07.010","article-title":"Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents","volume":"22","author":"Molina","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001326.pub2","article-title":"Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy","volume":"3","author":"Power","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/713604290","article-title":"Clinical experience with Norplant subdermal implant system as long-term contraception during adolescence","volume":"7","author":"Cardamakis","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4065\/73.1.10","article-title":"Levonorgestrel contraceptive implants in female patients 14 to 21 years old","volume":"73","author":"Suman","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib35","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.AOG.0000291575.93944.1a","article-title":"ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents","volume":"110","author":"American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2008.12.009","article-title":"Intrauterine devices for adolescents: a systematic review","volume":"79","author":"Deans","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2006.09.010","article-title":"Use of IUD and subsequent fertility\u2013follow-up after participation in a randomized clinical trial","volume":"75","author":"Hov","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02699200802253706","article-title":"Webb A.Experience of IUD\/IUS insertions and clinical performance in nulliparous women\u2013a pilot study","volume":"13","author":"Brockmeyer","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib42","first-page":"2","article-title":"Interventions for emergency contraception","volume":"16","author":"Cheng","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib43","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(02)11767-3","article-title":"Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial","volume":"360","author":"von Hertzen","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ajog.2004.05.011","article-title":"Tolerability of levonorgestrel emergency contraception in adolescents","volume":"191","author":"Harper","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.fertnstert.2006.12.088","article-title":"Pharmacokinetics of a single oral dose of 1.5-mg levonorgestrel when administered as 750-mug tablets or as 30-microg minipills","volume":"88","author":"Devoto","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"OG practice bulletin A No. 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2005.08.005","article-title":"Combined oral contraceptive use among women with hypertension: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib48","first-page":"13","article-title":"Harding k. Contraception and cardiovascular disorders","volume":"25","author":"Gupta","year":"1999","journal-title":"Br J Fam Plann"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib49","first-page":"229","article-title":"Contraception in women with special medical needs","volume":"24","author":"Neinstein","year":"1998","journal-title":"Compr Ther"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11886-009-0043-7","article-title":"Choosing the best contraceptive method for the adult with congenital heart disease","volume":"11","author":"Silversides","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib52","first-page":"62","article-title":"Contraception for women with epilepsy","volume":"6","author":"Burakgazi","year":"2009","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/met.2005.3.244","article-title":"Contraception for women with diabetes mellitus","volume":"3","author":"Damm","year":"2005","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003990.pub3","article-title":"Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2","volume":"4","author":"Visser","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0010-7824(95)00080-T","article-title":"A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives","volume":"51","author":"Bassol","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007245.pub2","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","volume":"4","author":"Chin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib57_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.contraception.2009.04.007","article-title":"The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review","volume":"80","author":"Kapp","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib57_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0891-5245(96)90001-2","article-title":"Use of Depo-Provera in teens","volume":"10","author":"Khoiny","year":"1996","journal-title":"Journal of Pediatric Health Care"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.contraception.2009.01.021","article-title":"Hormonal contraceptive use among women with liver tumors: a systematic review","volume":"80","author":"Kapp","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006261.pub2","article-title":"Steroid hormones for contraception in women with sickle cell disease","volume":"18","author":"Manchikanti","year":"2007","journal-title":"Cochrane Datase Syst Rev"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib61","unstructured":"Faculty of sexual and reproductive healthcare clinical effectiveness unit. Sexual and Reproductive Health for individuals with inflammatory bowel disease FSRH Guidance (June 2009)."},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib62","first-page":"57","article-title":"Contraception safe for HIV-positive women","volume":"24","year":"2009","journal-title":"AIDS Alert"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.contraception.2009.03.014","article-title":"Fourteen million women with limited options: HIV\/AIDS and highly effective reversible contraception in sub-Saharan Africa","volume":"80","author":"Stuart","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib64","first-page":"583","article-title":"Contraceptive considerations in obese women SFP Guideline 2009","volume":"80","author":"Higginbotham","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2007.11.012","article-title":"Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis","volume":"77","author":"Trussell","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.contraception.2009.04.006","article-title":"Progestogen-only contraceptive use in obese women","volume":"80","author":"Curtis","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.017_bib68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"Dinger","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341000043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341000043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:34:55Z","timestamp":1685579695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169341000043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S152169341000043X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2010.02.017","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}